2022-12-02

Clinical Lab Products: The Future of Cervical Cancer Screening is Here

Molly Broache, Associate Director, Medical Affairs for US IDS discusses the future of cervical cancer screening

The future of cervical cancer screening is here. Featured in Clinical Lab Products, Associate Director of Medical Affairs Molly Broache notes that in today’s world where patients are catching up on missed screenings, adding pressure on already-pressured labs, it’s that much more important to take advantage of instruments and assays that do more and do better. The BD Onclarity HPV Assay is a perfect example with its cutting-edge approach to HPV testing.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

FiercePharma
New BD survey finds nearly half of women unaware of STI treatment options
New study shows substandard approaches to diagnosis and treatment for vaginal discharge syndromes
Vaginitis | News & Updates
Press release: New study shows substandard approaches to diagnosis and treatment for vaginal discharge syndromes
Contemporary OB/GYN
Cervical Cancer | News & Updates
Contemporary OB/GYN: Harris Poll study from BD reveals knowledge gap and inequity in HPV screening and cervical cancer